SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,540.83 3.11
( 0.00%)

Global Indices

Nasdaq

53,294.39 514.18
(0.97%)

Dow Jones

7,693.51 31.35
(0.41%)

Hang Seng

65,893.13 -323.66
(-0.49%)

Nikkei 225

10,809.01 60.85
(0.57%)

Forex

USD-INR

95.67 0.05
(0.05%)

EUR-INR

111.76 0.57
(0.51%)

GBP-INR

130.35 0.55
(0.42%)

JPY-INR

0.60 0.00
(0.11%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

356.2353295

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

50.45

9085.93

EPS(TTM)

Face Value()

Div & Yield %

19.54

0.51

Back

Rossari Biotech consolidated net profit rises 4.46% in the June 2026 quarter

Jul 18,2026

Net profit of Rossari Biotech rose 4.46% to Rs 35.10 crore in the quarter ended June 2026 as against Rs 33.60 crore during the previous quarter ended June 2025. Sales rose 28.23% to Rs 697.20 crore in the quarter ended June 2026 as against Rs 543.72 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	697.20	543.72	28
OPM %	11.56	12.48	-
PBDT	73.29	63.85	15
PBT	47.67	46.10	3
NP	35.10	33.60	4

77,540.83 3.11 ( 0.00%)

53,294.39 514.18 (0.97%)

7,693.51 31.35 (0.41%)

65,893.13 -323.66 (-0.49%)

10,809.01 60.85 (0.57%)

95.67 0.05 (0.05%)

111.76 0.57 (0.51%)

130.35 0.55 (0.42%)

0.60 0.00 (0.11%)